Arcus Biosciences, Inc.
NYSE:RCUS
9.54 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 258 | 117 | 112 | 382.882 | 77.517 | 15 | 8.353 | 1.413 | 0 |
| Cost of Revenue
| 0 | 340 | 14 | 7.057 | 159 | 78.481 | 49.646 | 2.612 | 1.314 |
| Gross Profit
| 258 | -223 | 98 | 375.825 | -81.483 | -63.481 | -41.293 | -1.199 | -1.314 |
| Gross Profit Ratio
| 1 | -1.906 | 0.875 | 0.982 | -1.051 | -4.232 | -4.943 | -0.849 | 0 |
| Reseach & Development Expenses
| 448 | 340 | 288 | 256.348 | 159.348 | 78.481 | 49.646 | 47.218 | 14.247 |
| General & Administrative Expenses
| 120 | 117 | 104 | 72.286 | 42.404 | 25.228 | 13.566 | 7.636 | 3.935 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 120 | 117 | 104 | 72.286 | 42.404 | 25.228 | 13.566 | 7.636 | 3.935 |
| Other Expenses
| 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 588 | 457 | 392 | 328.634 | 201.752 | 103.709 | 63.212 | 54.854 | 18.182 |
| Operating Income
| -330 | -340 | -280 | 54.248 | -124.235 | -88.709 | -54.859 | -53.441 | -18.182 |
| Operating Income Ratio
| -1.279 | -2.906 | -2.5 | 0.142 | -1.603 | -5.914 | -6.568 | -37.821 | 0 |
| Total Other Income Expenses Net
| 47 | 39 | 14 | 0.397 | 1.377 | 3.999 | 5.265 | 0.359 | 0.212 |
| Income Before Tax
| -283 | -301 | -266 | 54.645 | -122.858 | -84.71 | -49.594 | -53.082 | -17.97 |
| Income Before Tax Ratio
| -1.097 | -2.573 | -2.375 | 0.143 | -1.585 | -5.647 | -5.937 | -37.567 | 0 |
| Income Tax Expense
| 1 | 6 | 1 | 1.815 | -6.181 | -8.779 | 5.265 | 0 | 0 |
| Net Income
| -283 | -307 | -267 | 53 | -116.677 | -75.931 | -49.594 | -53.082 | -17.97 |
| Net Income Ratio
| -1.097 | -2.624 | -2.384 | 0.138 | -1.505 | -5.062 | -5.937 | -37.567 | 0 |
| EPS
| -3.14 | -4.15 | -3.71 | 0.76 | -2.13 | -1.73 | -1.43 | -1.25 | -0.73 |
| EPS Diluted
| -3.14 | -4.15 | -3.71 | 0.71 | -2.13 | -1.73 | -1.43 | -1.25 | -0.73 |
| EBITDA
| -269 | -283 | -250 | 61.962 | -118.467 | -81.132 | -51.195 | -50.829 | -16.868 |
| EBITDA Ratio
| -1.043 | -2.419 | -2.357 | 0.143 | -1.611 | -5.914 | -6.715 | -35.972 | 0 |